13 Jul Matthew Dahl
Posted at 17:23h
in
Bio
Matt Dahl joined the Manitoba Centre for Health Policy (MCHP) in 2001 as a data analyst after completing his undergraduate studies at the University of Manitoba. He has 20+ years of experience applying different programming (SAS) techniques to access and analyze large administrative databases. With a focus on pharmacoepidemiology studies, he has become an expert in the use of pharmaceutical claims data and the appropriate methods to analyze the data at MCHP.
Matt has been a member of the Manitoba CNODES site team since 2011 and joined the CNODES steering committee in 2021. He has been involved in many CNODES projects, serving in both the Manitoba site analyst and the National lead analyst roles.
CNODES Projects
Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study
Lead Analyst, CPRDVentricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson’s Disease
Analyst, ManitobaA multicenter observational study of incretin-based drugs and heart failure
Analyst, ManitobaA multicenter observational study of incretin-based drugs and heart failure
Lead AnalystSerotonin-norepinephrine reuptake inhibitors and the risk of AKI: A cohort study of eight administrative databases and meta-analysis
Analyst, ManitobaHigher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases
Analyst, ManitobaProton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
Analyst, ManitobaAssociation between incretin-based drugs and the risk of acute pancreatitis
Lead AnalystAssociation between incretin-based drugs and the risk of acute pancreatitis
Analyst, Manitoba- Analyst, Manitoba
Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy
Analyst, ManitobaAtypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data
Analyst, Manitoba- Lead Analyst
- Lead Analyst
- Analyst, Manitoba
Impact of using concomitant conventional DMARDs on adherence to biologic DMARD treatment in rheumatoid arthritis: Multi-centre, population-based cohort study
Analyst, ManitobaComparative safety of direct oral anticoagulants and warfarin in patients with venous thromboembolism: a multicenter observational study of administrative databases
Lead AnalystComparative safety of direct oral anticoagulants and warfarin in patients with venous thromboembolism: a multicenter observational study of administrative databases
Analyst, ManitobaComparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study
Analyst, ManitobaComparison of pregnancy outcomes of patients treated with ondansetron vs alternative antiemetic medications in a multinational, population-based cohort
Analyst, ManitobaUtilization and adverse outcomes of fluconazole during pregnancy
Analyst, ManitobaHealth Canada and European Medicines Agency collaboration: Characterising the risk of major bleeding in patients with non-valvular atrial fibrillation: Non-interventional study of patients taking direct oral anticoagulants
Analyst, ManitobaCNODES simulated data platform
CollaboratorAddressing confounding through extreme cohort restriction in large datasets: CNODES analysis of PPIs and pneumonia
CollaboratorPrescription patterns of ranitidine in Canada
Analyst, ManitobaSodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
Analyst, ManitobaSodium-glucose co-transporter-2 inhibitors and the risk of urosepsis: A multi-site, prevalent new-user cohort study
Analyst, ManitobaOff-label postpartum use of domperidone in Canada: a multidatabase cohort study
Lead AnalystOff-label postpartum use of domperidone in Canada: a multidatabase cohort study
Analyst, ManitobaHydrochlorothiazide use and the risk of skin cancer
Lead AnalystHydrochlorothiazide use and the risk of skin cancer
Analyst, ManitobaSodium-glucose cotransporter 2 inhibitors and the risk of below-knee amputation: a multicenter observational study
Analyst, ManitobaSodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis: a multicenter cohort study
Analyst, ManitobaSafety of bowel cleansers when combined with the bisacodyl stimulant laxative
Analyst, ManitobaUse of systemic oral fluoroquinolones in Canada
Lead AnalystUse of systemic oral fluoroquinolones in Canada
Analyst, ManitobaFluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study
Lead AnalystFluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study
Analyst, ManitobaFluoroquinolone use and acute bacterial sinusitis
Lead AnalystFluoroquinolone use and acute bacterial sinusitis
Analyst, ManitobaComparative effectiveness of fluoroquinolone antibiotic use in uncomplicated acute exacerbations of chronic obstructive pulmonary disease: a multi-cohort study
Lead AnalystComparative effectiveness of fluoroquinolone antibiotic use in uncomplicated acute exacerbations of chronic obstructive pulmonary disease: a multi-cohort study
Analyst, ManitobaCharacteristics of new users of newer antidiabetic drugs in Canada and the United Kingdom
Analyst, ManitobaUtilization of angiotensin receptor blockers (ARBs) in Canada
Analyst, ManitobaMethadone containing products used for opioid use disorder
Lead AnalystMethadone containing products used for opioid use disorder
Analyst, ManitobaEffectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi-database cohort study with meta-analysis
Analyst, Manitoba- Analyst, Manitoba
Patterns of steroid utilization in COVID-19 patients
Analyst, ManitobaNatural coagulopathy and characteristics of its treatment in COVID-19 patients
Analyst, ManitobaReliability of COVID-19 case definitions in administrative and clinical databases
Site Investigator, ManitobaReliability of COVID-19 case definitions in administrative and clinical databases
Analyst, ManitobaChanges in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis
Lead Analyst, ManitobaChanges in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis
Analyst, Manitoba